VNRX vs XYL · rev $1.4M vs P/E 27, rev $4.46B
Volitionrx Ltd (VNRX) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Volitionrx Ltd (VNRX) is a medical devices company listed on AMEX.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported VNRX revenue for 2026-06-30 was $1.4M. Net income was -$14.0M. Revenue was up 40.5% from 2026-03-31 to 2026-06-30. VNRX currently screens at market cap $15.9M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
VNRX currently screens at market cap $15.9M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the VNRX and XYL stock pages for the full models.
Not investment advice.